Vestagen pulls in $8.25 million for high-tech medical scrub uniforms

Vestagen Technical Textiles completed an $8.25 million financing to accelerate commercial development of its Vestex line of high-tech medical scrub uniforms and other protective clothing. The Orlando, FL-based company bills the product as part of "a new class of medical devices" designed to repel liquids and possess antimicrobial properties. New investor Advent Life Sciences led the round. Alliance Healthcare Investment Fund also participated along with original investor V-Ten Capital and private investors. Item

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.